外傷固定：グローバル市場分析と予測...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 14
1.2 List of Figures 19
2 Introduction 21
2.1 Catalyst 22
2.2 Related Reports 23
2.3 Upcoming Related Reports 23
3 Disease Overview 24
3.1 Anatomy and Physiology 24
3.1.1 Bone Biology 24
3.1.2 Skeletal Structure 24
3.2 Pathophysiology 27
3.2.1 Overview 27
3.2.2 Post-Traumatic Arthritis 27
3.2.3 Fracture 27
3.3 Clinical Presentation 28
3.3.1 Symptoms 28
3.3.2 Fracture Types 29
3.3.3 Fractures by Location 31
3.3.4 Hip Injury 33
3.4 Clinical Outcomes 34
3.4.1 Immobilization 34
3.4.2 Plates and Screws 35
3.4.3 Intramedullary Nails 37
3.4.4 Hip Fixation Device Options 37
3.4.5 External Fixation 40
4 Industry Overview 41
4.1 Overview 41
4.2 Procedure Trends 43
4.2.1 US 43
4.2.2 EU 44
4.2.3 APAC 45
4.2.4 South America 46
4.3 Market Access 47
4.3.1 US 47
4.3.2 EU 53
4.3.3 APAC 60
4.3.4 South America 67
4.4 Regulatory Issues / Recalls 70
4.4.1 Rigid FX FDA Warning Letter 70
4.4.2 DePuy Orthopedics LBS Lower Extremity Dovetail Intercalary Component Recall 70
4.5 Mergers, Acquisitions and Partnerships 71
4.5.1 Zimmer Acquires NORMED Medizin-Technik 71
4.5.2 Smith & Nephew Acquires Adler Mediequip Private Limited 71
4.5.3 Smith & Nephew plc Announces Acquisition of Brazil Distribution Business 71
4.5.4 Biomet Inc. Acquires DePuy Trauma 71
4.5.5 Zimmer Acquires ExtraOrtho XtraFix External Fixation Product Line 72
4.5.6 DePuy Orthopaedics (Johnson & Johnson) and Synthes Inc. Merge 72
4.5.7 Synthes Inc. and AO Foundation Partnership 72
4.6 Economic Impact 73
4.6.1 Developed Countries 73
4.6.2 Emerging Markets 74
4.7 Market Drivers 74
4.7.1 Rising Prevalence 74
4.7.2 Development Due to War 77
4.7.3 Bone Regeneration 78
4.7.4 Commoditization of Orthopedic Market 79
4.7.5 Patient Demand and Awareness 79
4.7.6 Technological Developments 80
4.7.7 Rising Competition and Innovation through Small Players 81
4.7.8 Materials Development 82
4.8 Market Opportunities 83
4.8.1 Mergers and Acquisitions 83
4.8.2 Emerging Markets 84
4.8.3 Extremities Growth 84
4.8.4 Capitalizing on Market Fragmentation 86
4.9 Market Barriers 87
4.9.1 Burden of Rising Regulation 87
4.9.2 Proving Efficacy 88
4.9.3 Pricing Pressures and Reimbursement 89
4.9.4 Medical Device Excise Tax 90
4.10 Substitutes 90
4.10.1 Joint Replacement 90
4.10.2 Generic Implants 91
4.10.3 External Fixation 92
5 Competitive Assessment 93
5.1 Overview 93
5.2 Global Market Share 93
5.2.1 Global Market Share 93
5.2.2 US Market Share 96
5.2.3 EU Market Share 100
5.3 Marketed Products 102
5.3.1 Key Internal Fixation Products 104
5.3.2 Key External Fixation Devices 135
6 Unmet Needs 139
6.1 Addressing the Complications 139
6.2 Advanced Materials Research 139
6.3 Improving Borderline Patient Treatment Outcomes 140
6.4 Bioabsorbable Technology Development 141
6.5 Centralization 141
6.6 Cost Containment 142
6.7 Drug-Eluting Implants 143
6.8 Long-Term Clinical Data 143
6.9 Trauma Registry 145
7 Pipeline Products 147
7.1 Overview 147
7.2 Product Profiles 147
7.2.1 Drug-Releasing Screws by Bioretec 147
7.2.2 Small Bone Innovations Arthrodesis Plates 147
7.2.3 Semprus Biosciences Trauma Fixation Devices 147
7.2.4 Nanova Inc. Bioabsorbable Bone Screws 147
7.2.5 CAMBfix Ltd. Pipeline 148
7.2.6 Nutek Orthopaedics LLC External Fixation Pipeline 148
7.2.7 Innovia LLC Develops IM Nail 148
8 Clinical Trials to Watch 149
8.1 Overview 149
8.2 Orthopedic Trauma Patient Quality of Life Trial 149
8.3 Non-Operative vs. Operative Management of Olecranon Fractures 150
8.4 Smith & Nephew INTUIT Hip Fracture Study 150
8.5 Distal Radius Fracture Fixation Comparison 151
8.6 Nails versus Plates for Femur Fractures in Dar es Salaam, Tanzania 151
9 Current and Future Players 152
9.1 Trends in Corporate Strategy 152
9.2 Company Profiles 153
9.2.1 Acumed 153
9.2.2 Biomet 155
9.2.3 DePuy Synthes International 157
9.2.4 Integra LifeSciences 159
9.2.5 Orthofix 161
9.2.6 OsteoMed 163
9.2.7 Small Bone Innovations, Inc. 164
9.2.8 Smith & Nephew 166
9.2.9 Stryker 168
9.2.10 Tornier 170
9.2.11 Trimed Inc. 172
9.2.12 Wright Medical 174
9.2.13 Zimmer 176
9.2.14 Companies in Trauma 179
10 Market Outlook 183
10.1 Major Markets Overview 183
10.2 US 186
10.3 EU 188
10.3.1 Overview 188
10.3.2 France 190
10.3.3 Germany 192
10.3.4 Italy 194
10.3.5 Spain 195
10.3.6 UK 197
10.4 APAC 199
10.4.1 Overview 199
10.4.2 Japan 199
10.4.3 China 200
10.4.4 India 202
10.5 South America 204
10.5.1 Brazil 204
11 Appendix 208
11.1 Abbreviations 208
11.2 Bibliography 210
11.3 Research Methodology 221
11.3.1 Overview 221
11.3.2 Coverage 221
11.3.3 Secondary Research 222
11.3.4 Forecasting Methodology 222
11.3.5 Primary Research – Key Opinion Leader Interviews 224
11.3.6 Primary Research – Physician Survey 224
11.3.7 Expert Panel Validation 226
11.4 Physicians and Specialists Included in this Study 226
11.4.1 Dr. Philippe Bellemère 226
11.4.2 Julio Duarte Clemente, MD, PhD. 226
11.4.3 Dr. Moussa Hamadouche 226
11.4.4 Dr. Vidhya Ravi 226
11.4.5 Robert M. Szabo, MD, MPH 227
11.4.6 Dr. Marcello Zaia Oliveira 227
11.4.7 Robert Zura, MD 227
11.5 About the Authors 228
11.5.1 Analysts 228
11.5.2 Global Head of Healthcare 229
11.6 About MediPoint 230
11.7 About GlobalData 230
11.8 Disclaimer 230